Across TCGA pan-cancer cohorts, TRAPPC2P8 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated TRAPPC2P8 data layer.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TRAPPC2P8 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TRAPPC2P8 expression acts as an unfavorable survival marker.
LUAD, KIRC, and ESCA are the cancer types where TRAPPC2P8 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.